Litcius/Paper detail

In Silico and In Vitro Evaluations of Fluorophoric Thiazolo-[2,3-b]quinazolinones as Anti-cancer Agents Targeting EGFR-TKD

Showkat Ahmad Mir, Ganesh Chandra Dash, Rajesh Kumar Meher, Prajna Parimita Mohanta, Kumar Sambhav Chopdar, Pranab Kishor Mohapatra, Iswar Baitharu, Ajaya Kumar Behera, Mukesh Kumar Raval, Binata Nayak

2022Applied Biochemistry and Biotechnology23 citationsDOI

Topics & Concepts

QuinazolinoneErlotinibChemistryIn silicoIn vitroEpidermal growth factor receptorEGFR inhibitorsDocking (animal)Cancer researchPharmacologyStereochemistryBiochemistryReceptorBiologyMedicineGeneNursingQuinazolinone synthesis and applicationsSynthesis and biological activitySynthesis and Characterization of Heterocyclic Compounds
In Silico and In Vitro Evaluations of Fluorophoric Thiazolo-[2,3-b]quinazolinones as Anti-cancer Agents Targeting EGFR-TKD | Litcius